1. Allergan's Botox still physician fave for migraine despite CGRP push — Lilly to sponsor Team USA in Tokyo Olympics — Gilead loses again in PrEP patent fight — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Product Rejected By FDA

Discussion in 'TherapeuticsMD' started by anonymous, Apr 14, 2017 at 1:00 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Looks like we aren't launching the new product. FDA shut us down. How long of a delay? Management won't say no surprise.